LNK-01009

N/A

Report date: 2025/04/11 13:35:40
NME

Base Information

Drug NameLNK-01009
Drug Alias NameLNK-01009
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase 2 inhibitors
TargetsTyrosine-protein kinase 2
Therapy Area/IndicationsMetabolic DiseasesLupus Erythematosus, SystemicInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesLynk Pharmaceutical (Hangzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLynk Pharmaceutical (Hangzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsMetabolic DiseasesLupus Erythematosus, SystemicInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A